Range Impact, Inc. (RNGE)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Range Land	2.71M		-	-					-	-
Corporate	1.00M		-	-					-	-
Range Security	-		684.20K	-					-	-
Range Reclaim	-		18.66M	4.83M					-	-
Range Reclaim Growth	-		286.20%	-					-	-
Pharmaceutical Operations	-		-	-					102.42K	163.36K
Pharmaceutical Operations Growth	-		-	-					-37.31%	-34.22%
Total	3.71M		19.35M	4.83M					102.42K	163.36K
Total Growth	-		300.36%	-					-37.31%	-34.22%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
United States	3.71M		19.35M	4.83M					102.42K	163.36K
United States Growth	-		300.36%	-					-37.31%	-34.22%
Total	3.71M		19.35M	4.83M					102.42K	163.36K
Total Growth	-		300.36%	-					-37.31%	-34.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error